{
    "Figure 1": "Representative chiral 1-substituted tetrahydro-3-benzazepine drugs",
    "Figure 2": "Stereoselectivity model. (a) Coordination of oxazole ligand and olefin to the iridium center. (b) Quadrant model based on the steric influence of the ligand seen from the olefin. (c) Predicted and experimental stereochemical outcomes for the hydrogenation of ene-carbamates",
    "Scheme 1": "Representative Catalytic Approaches to Chiral 1-Substituted Tetrahydro-3-benzazepine Motifs and This Work",
    "Scheme 2": "Synthesis of Cyclic Ene-carbamates",
    "Scheme 3": "Asymmetric Hydrogenation of Aryl-Substituted Ene-carbamatesa  aReaction conditions 0.05 mmol substrate, 1 mol A, 1 mL of DCM, 100 bar H2, 16 h, rt. The stereochemistry was tentatively assigned by assuming a similar hydrogenation pathway as that of1a, the absolute configuration of which was assigned by comparing the sign of the optical rotation with the literature value after the reduction of2awith LiAlH4. Isolated yields. Enantiomeric excess was determined by SFC analysis using chiral stationary phases",
    "Scheme 4": "Asymmetric Hydrogenation of Alkyl-Substituted Ene-carbamatesa  aReaction conditions 0.05 mmol substrate, 1 mol A, 1 mL of DCM, 100 bar H2, 16 h, rt, unless stated otherwise. The stereochemistry was tentatively assigned by assuming a similar hydrogenation pathway to1a, the absolute configuration of which was assigned by comparing the sign of the optical rotation with the literature value after the reduction of2awith LiAlH4. Isolated yields. Enantiomeric excess was determined by SFC analysis using chiral stationary phases. b2 mol Awas used",
    "Scheme 5": "Gram-Scale Asymmetric Hydrogenation and Applications",
    "Table 1": "Optimization of Reaction Conditionsad"
}